Gabe Hoffman’s Accipiter Capital Scores Big With Orchid Cellmark Investment

Accipiter Capital is an activist hedge fund founded by Gabe Hoffman in 2002. Prior to starting Accipiter, Hoffman worked at Welch Capital Partners covering healthcare stocks. The most distinctive characteristic of Accipiter is that it is an activist hedge fund like Bill Ackman’s Pershing Square. We like activist hedge funds because activist investing requires additional skills and when done right yields much higher returns. It is also easier to imitate activist investors because they have to report their large activist investments within 10 days. The downside of imitating activist investors is that there are several other people doing the same thing and this may push prices higher as soon as an 13D form is filed.

Bill Ackman in front of Perishi

Last year on March 10th Accipiter filed a 13D firm disclosing that it owns 13.09% of Orchid Cellmark’s (ORCH) outstanding shares. ORCH’s average stock price during the 10 days prior to this filing was around $1.45. The stock price closed at $1.59 on March 10th. So, investors who imitated Accipiter had to pay at least a 10% premium over the prevailing price before the filing. The critical question is this: Does it still make sense to pay a 10% premium to imitate Accipiter?

If you are a small investor and have instant access to 13D filings, you could have initiated a small position in ORCH on March 10th. If you were slow or had to deplow $100K or more, the premium you had to pay would actually be around 20%. ORCH closed at $1.76 on March 11th, 2010. By the end of April ORCH’s stock price reached $2 per share. However, nothing significant really happened here and the stock price went down to $1.35 by the end of August as recession expectations peaked in the market. By the end of November, ORCH reached $1.60. Investors who were able to buy this stock on March 10th didn’t make anything in 8 months. Investors who bought it on March 11th were still under water at the end of November.

However, the stock prices started to climb in December and reached $2 by the end of 2010. Then it stayed there until April 5th. On April 6th LabCorp (LH) announced that it will buy ORCH for $2.80 in cash tender offer.

On Friday Accipiter filed an amendment to its original 13D filing. It stated that it tendered all of its 3.9 Million ORCH shares. This means Accipiter made nearly 95% from its ORCH investment in 15 months. Investors who imitated Accipiter immediately made 75% if they were patient enough.

We didn’t cherry pick this example to show that imitating hedge funds could yield high returns. We will cover other activist investments, so you can drive your own conclusions.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Rito Pls Buff: The 10 Least Played Champions in LoL Season 4

10 Covers of Popular Songs that are Better than the Originals

Must See TV: The 9 Most Anticipated Shows of 2015

The 15 Biggest Box Office Bombs of All Time

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!